Stock AVTE AEROVATE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Aerovate Therapeutics, Inc.

Equities

AVTE

US0080641071

Real-time Estimate Cboe BZX
Other stock markets
 20:19:21 13/05/2024 BST 		5-day change 1st Jan Change
19.34 USD -2.47% Intraday chart for Aerovate Therapeutics, Inc. -4.68% -13.15%
04-12 Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing MT
04-04 Aerovate Therapeutics Insider Sold Shares Worth $300,033, According to a Recent SEC Filing MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing
MT
Aerovate Therapeutics Insider Sold Shares Worth $300,033, According to a Recent SEC Filing
MT
Aerovate Therapeutics Insider Sold Shares Worth $908,046, According to a Recent SEC Filing
MT
Aerovate Therapeutics, Inc. Announces Board Changes
CI
Aerovate Therapeutics Insider Sold Shares Worth $165,628, According to a Recent SEC Filing
MT
Aerovate Therapeutics Insider Sold Shares Worth $203,237, According to a Recent SEC Filing
MT
Aerovate Therapeutics, Inc. Appoints Habib Dable as Member of Board of Directors
CI
Aerovate Therapeutics, Inc. Appoints Donald Santel To Its Board of Directors
CI
Insider Sell: Aerovate Therapeutics
MT
Insider Sell: Aerovate Therapeutics
MT
Insider Sell: Aerovate Therapeutics
MT
Insider Sell: Aerovate Therapeutics
MT
Insider Sell: Aerovate Therapeutics
MT
Insider Sell: Aerovate Therapeutics
MT
Insider Sell: Aerovate Therapeutics
MT
Aerovate Therapeutics, Inc. Announces New Executive Appointments
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVTE Stock
  4. News Aerovate Therapeutics, Inc.
  5. Insiders